Get the app
US › Healthcare

Kazia Therapeutics Ltd ADR (KZIA)

US · Healthcare · Biotechnology

$7.25-2.03%
Last close · 2026-10-16

Key statistics

Market cap
$138.9M
Forward P/E
12.8
P/B
4.45
Book value
$2.84
EPS (TTM)
$-6.85
52-week high
$17.40
52-week low
$4.86
50-day MA
$11.81
200-day MA
$10.45
Beta
2.27

Analyst view

Analysts rate Kazia Therapeutics Ltd ADR a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $28.37.

Shareholding

Insiders
15.42%
Institutions
31.70%

Largest institutional holders

FundStake
Boxer Capital Management, LLC4.33%
F.L.Putnam Investment Management3.21%
Bleichroeder LP3.09%
Ikarian Capital, LLC3.06%
Dauntless Investment Group, LLC2.74%
Stonepine Capital Management Llc2.67%
Point72 Asset Management, L.P.1.55%
Ensign Peak Advisors Inc0.86%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Kazia Therapeutics Ltd ADR — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.